Concepedia

Publication | Open Access

Rationale and design of the Mineralocorticoid Receptor Antagonists in End-Stage Renal Disease Study (MiREnDa)

DOIFull Paper Access

24

Citations

35

References

2013

Year

Fabian Hammer, Vera Krane, Stefan Störk, Christian Roser, K. Hofmann, Nadine Pollak, Bruno Allolio, Christoph Wanner
Nephrology Dialysis Transplantation

Abstract

MiREnDa will investigate CV efficacy and safety of spironolactone in haemodialysis patients [clinical trials.gov NCT01691053].

References

YearCitations

Page 1